Evidence for impaired mitoxantrone and vinblastine binding in P388 murine leukemia cells with multidrug resistance

Rosemarie Pincus, I. David Goldman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Multidrug resistance is associated with a P170 glycoprotein efflux pump that limits net drug accumulation in resistant cell lines. Other evidence has suggested that diminished net drug uptake in multidrug resistant (MDR) cells is due to decreased drug binding as well. To assess the contribution of binding differences to net drug accumulation and retention in MDR cells, mitoxantrone and vinblastine, two agents commonly associated with the MDR phenotype but with different mechanisms of action and intracellular binding sites, were studied in P388 murine leukemia cells. For both drugs, resistance was associated with a marked reduction in tightly bound drug which can account for the diminished net drug accumulation in this cell line; even at 1 μM vinblastine when the exchangeable component was one-half that of the sensitive cells, the nonexchangeable component was only one-seventh. For mitoxantrone, the exchangeable drug component was greater in resistant cells at low drug levels (1 μM) and similar at high drug levels (10 μM). For vinblastine, the exchangeable drug component was decreased in the resistant cells at 1 μM, but the difference compared to sensitive cells became neglible at 10 μM. The data indicate that diminished net drug uptake in the P388 MDR cell line was associated with a marked decrease in tightly bound, i.e. nonexchangeable, drug fractions for both mitoxantrone and vinblastine. Therefore, alterations in intracellular binding are an important factor in the decreased cellular uptake and retention of drugs in the multidrug resistance phenomenon. The relationship between these changes and the P170 efflux pump requires further clarification.

Original languageEnglish (US)
Pages (from-to)2625-2635
Number of pages11
JournalBiochemical Pharmacology
Volume40
Issue number12
DOIs
StatePublished - Dec 15 1990
Externally publishedYes

Fingerprint

Leukemia P388
Mitoxantrone
Vinblastine
Multiple Drug Resistance
Pharmaceutical Preparations
Cells
Cell Line
Pumps
Cellular Structures
Drug Resistance

ASJC Scopus subject areas

  • Pharmacology

Cite this

Evidence for impaired mitoxantrone and vinblastine binding in P388 murine leukemia cells with multidrug resistance. / Pincus, Rosemarie; Goldman, I. David.

In: Biochemical Pharmacology, Vol. 40, No. 12, 15.12.1990, p. 2625-2635.

Research output: Contribution to journalArticle

@article{8eca6bfbb2ae427fb620419318fe5bbd,
title = "Evidence for impaired mitoxantrone and vinblastine binding in P388 murine leukemia cells with multidrug resistance",
abstract = "Multidrug resistance is associated with a P170 glycoprotein efflux pump that limits net drug accumulation in resistant cell lines. Other evidence has suggested that diminished net drug uptake in multidrug resistant (MDR) cells is due to decreased drug binding as well. To assess the contribution of binding differences to net drug accumulation and retention in MDR cells, mitoxantrone and vinblastine, two agents commonly associated with the MDR phenotype but with different mechanisms of action and intracellular binding sites, were studied in P388 murine leukemia cells. For both drugs, resistance was associated with a marked reduction in tightly bound drug which can account for the diminished net drug accumulation in this cell line; even at 1 μM vinblastine when the exchangeable component was one-half that of the sensitive cells, the nonexchangeable component was only one-seventh. For mitoxantrone, the exchangeable drug component was greater in resistant cells at low drug levels (1 μM) and similar at high drug levels (10 μM). For vinblastine, the exchangeable drug component was decreased in the resistant cells at 1 μM, but the difference compared to sensitive cells became neglible at 10 μM. The data indicate that diminished net drug uptake in the P388 MDR cell line was associated with a marked decrease in tightly bound, i.e. nonexchangeable, drug fractions for both mitoxantrone and vinblastine. Therefore, alterations in intracellular binding are an important factor in the decreased cellular uptake and retention of drugs in the multidrug resistance phenomenon. The relationship between these changes and the P170 efflux pump requires further clarification.",
author = "Rosemarie Pincus and Goldman, {I. David}",
year = "1990",
month = "12",
day = "15",
doi = "10.1016/0006-2952(90)90580-E",
language = "English (US)",
volume = "40",
pages = "2625--2635",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Evidence for impaired mitoxantrone and vinblastine binding in P388 murine leukemia cells with multidrug resistance

AU - Pincus, Rosemarie

AU - Goldman, I. David

PY - 1990/12/15

Y1 - 1990/12/15

N2 - Multidrug resistance is associated with a P170 glycoprotein efflux pump that limits net drug accumulation in resistant cell lines. Other evidence has suggested that diminished net drug uptake in multidrug resistant (MDR) cells is due to decreased drug binding as well. To assess the contribution of binding differences to net drug accumulation and retention in MDR cells, mitoxantrone and vinblastine, two agents commonly associated with the MDR phenotype but with different mechanisms of action and intracellular binding sites, were studied in P388 murine leukemia cells. For both drugs, resistance was associated with a marked reduction in tightly bound drug which can account for the diminished net drug accumulation in this cell line; even at 1 μM vinblastine when the exchangeable component was one-half that of the sensitive cells, the nonexchangeable component was only one-seventh. For mitoxantrone, the exchangeable drug component was greater in resistant cells at low drug levels (1 μM) and similar at high drug levels (10 μM). For vinblastine, the exchangeable drug component was decreased in the resistant cells at 1 μM, but the difference compared to sensitive cells became neglible at 10 μM. The data indicate that diminished net drug uptake in the P388 MDR cell line was associated with a marked decrease in tightly bound, i.e. nonexchangeable, drug fractions for both mitoxantrone and vinblastine. Therefore, alterations in intracellular binding are an important factor in the decreased cellular uptake and retention of drugs in the multidrug resistance phenomenon. The relationship between these changes and the P170 efflux pump requires further clarification.

AB - Multidrug resistance is associated with a P170 glycoprotein efflux pump that limits net drug accumulation in resistant cell lines. Other evidence has suggested that diminished net drug uptake in multidrug resistant (MDR) cells is due to decreased drug binding as well. To assess the contribution of binding differences to net drug accumulation and retention in MDR cells, mitoxantrone and vinblastine, two agents commonly associated with the MDR phenotype but with different mechanisms of action and intracellular binding sites, were studied in P388 murine leukemia cells. For both drugs, resistance was associated with a marked reduction in tightly bound drug which can account for the diminished net drug accumulation in this cell line; even at 1 μM vinblastine when the exchangeable component was one-half that of the sensitive cells, the nonexchangeable component was only one-seventh. For mitoxantrone, the exchangeable drug component was greater in resistant cells at low drug levels (1 μM) and similar at high drug levels (10 μM). For vinblastine, the exchangeable drug component was decreased in the resistant cells at 1 μM, but the difference compared to sensitive cells became neglible at 10 μM. The data indicate that diminished net drug uptake in the P388 MDR cell line was associated with a marked decrease in tightly bound, i.e. nonexchangeable, drug fractions for both mitoxantrone and vinblastine. Therefore, alterations in intracellular binding are an important factor in the decreased cellular uptake and retention of drugs in the multidrug resistance phenomenon. The relationship between these changes and the P170 efflux pump requires further clarification.

UR - http://www.scopus.com/inward/record.url?scp=0025688982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025688982&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(90)90580-E

DO - 10.1016/0006-2952(90)90580-E

M3 - Article

C2 - 1979735

AN - SCOPUS:0025688982

VL - 40

SP - 2625

EP - 2635

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -